A glance on current progress of innovative drug R&D in china
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Presentation
- By: SANG, Guowei (Chinese Pharmaceutical Association, Beijing, China)
Prior to the China 10th 5-Year Plan (2001-2005), the most of Chinese pharmaceutical companies basically only focused on the generic drug development as only a few of them are affordable and willing to invest on innovative drug development. With the new national policy on Innovation Society promulgated by the State Council since 2005, the.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.